LifeMD, Inc.
NASDAQ Global MarketTotal Valuation
LifeMD, Inc. carries a market capitalization of 159.05M, placing it among publicly traded companies globally. Its enterprise value stands at -28.31M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 159.05M |
| Enterprise Value | -28.31M |
Share Statistics
LifeMD, Inc. currently has 47.53M shares outstanding.
| Shares Outstanding | 47.53M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Position
LifeMD, Inc. maintains a current ratio of 1.04, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 41.05, indicating elevated leverage, while an interest coverage ratio of -14.18 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.04 |
| Quick Ratio | 0.89 |
| Debt / Equity | 41.05 |
| Debt / EBITDA | -0.59 |
| Interest Coverage | -14.18 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | 7.25 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 8.14 |
Taxes
| Income Tax | 45,721.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
LifeMD, Inc.'s stock has declined approximately -1.9958% over the past 52 weeks. The 50-day moving average sits at 23.58, while the 200-day moving average is 23.20.
| Beta (5Y) | N/A |
| 52-Week Price Change | -1.9958% |
| 50-Day Moving Average | 23.58 |
| 200-Day Moving Average | 23.20 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -10.42M, while operating income came in at -18.03M.
| Revenue | 179.63M |
| Gross Profit | 154.64M |
| Operating Income | -18.03M |
| Pretax Income | -19.86M |
| Net Income | 5.21M |
| EBITDA | -10.42M |
| EBIT | -18.03M |
| Earnings Per Share (EPS) | N/A |
Balance Sheet
LifeMD, Inc. holds 34.48M in cash and equivalents against 6.17M in total debt, resulting in a net debt position of -34.48M. Total book value stands at -237.78M, with working capital of 2.11M providing operational flexibility.
| Cash & Cash Equivalents | 34.48M |
| Total Debt | 6.17M |
| Net Debt | -34.48M |
| Equity (Book Value) | -237.78M |
| Book Value Per Share | N/A |
| Working Capital | 2.11M |
Cash Flow
LifeMD, Inc. produced 5.66M in operating cash flow over the past twelve months.
| Operating Cash Flow | 5.66M |
| Capital Expenditures | -1.86M |
| Free Cash Flow | 3.80M |
| FCF Per Share | N/A |
Margins
LifeMD, Inc. operates with a gross margin of 86.08, reflecting its pricing power and cost economics. The operating margin of -10.04 and net profit margin of 2.90 provide insight into operational efficiency.
| Gross Margin | 86.08 |
| Operating Margin | -10.04 |
| Pretax Margin | -11.06 |
| Profit Margin | 2.90 |
| EBITDA Margin | -5.80 |
Scores
LifeMD, Inc. posts an Altman Z-Score of -3.57, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -3.57 |